摘要
随着人口老龄化的进程,慢性阻塞性肺疾病(简称慢阻肺)的发病率逐年增加。慢阻肺稳定期药物治疗旨在预防与控制症状,减少急性加重的程度与频率,提高运动耐力与生活质量。世界卫生组织将吸入治疗推荐为慢阻肺的首选疗法,使用吸入剂的依从性又决定了慢阻肺稳定期的控制情况。本文就慢阻肺患者使用吸入剂的现状、影响因素及干预措施等进行综述。
With the aging of the population,the incidence of chronic obstructive pulmonary disease(COPD)is increasing year by year.Drug treatment in the stable stage of COPD is to prevent and control symptoms,reduce the degree and frequency of acute exacerbation,and improve exercise endurance and quality of life.The World Health Organization recommends inhalation as the first choice for COPD,and the compliance of inhalers determines the control of COPD in the stable period.This paper reviewed the current situation,influencing factors and interventions of inhalants in patients with COPD.
作者
刘冀衡
谢倩
黄丽
阎昱升
吴璐
汤渝玲
刘晓慧
LIU Ji-heng;XIE Qian;HUANG Li;YAN Yu-sheng;WU Lu;TANG Yu-ling;LIU Xiao-hui(First Hospital of Changsha,Changsha 410005;Huaihua Hospital of Traditional Chinese Medicine,Huaihua Hunan 418099;Zhuzhou Central Hospital,Zhuzhou Hunan 412007)
出处
《中南药学》
CAS
2022年第5期1113-1117,共5页
Central South Pharmacy
基金
湖南省卫生健康委科研计划课题项目(No.20200216)。
关键词
慢性阻塞性肺疾病
吸入剂
用药依从性
chronic obstructive pulmonary disease
inhalers
medication compliance
